| Filed On | Filing |
|---|---|
| 09 Oct 2026 | 6-K |
| 11 Sep 2026 | 6-K |
| 09 Sep 2026 |
Form 4: Schonharting Florian, Director
Granted 2,303 Share Options (Right to Buy) |
| 14 Aug 2026 | SCHEDULE 13G/A |
| 14 Aug 2026 | SCHEDULE 13G/A |
| 13 Aug 2026 |
Form 4: Moore Duncan, Director
Granted 2,202 Share Options (Right to Buy) |
| 13 Aug 2026 |
Form 4: Hanley Dermot John, Director
Granted 2,202 Share Options (Right to Buy) |
| 13 Aug 2026 |
Form 4: Forer Michael, Director
Granted 102,202 Share Options (Right to Buy) |
| 06 Aug 2026 | 6-K |
| 26 Jun 2026 | 6-K |
| 04 Jun 2026 | 6-K |
| 21 May 2026 | 6-K |
| 19 May 2026 | EFFECT |
| 18 May 2026 | SCHEDULE 13G/A |
| 15 May 2026 | CORRESP |
| 15 May 2026 | UPLOAD |
| 15 May 2026 | SCHEDULE 13G/A |
| 14 May 2026 | 6-K |
| 14 May 2026 | F-3 |
| 14 May 2026 | 424B5 |
Loading...
